Encrypted login | home

Program Information

Evaluation of Monte Carlo Simulations Performance for Pediatric Brachytherapy Dosimetry

no image available
C Chatzipapas

C Chatzipapas1*, P Papadimitroulas2 , G Loudos3 , N Papanikolaou4 , G Kagadis1 , (1) University Patras, Rion, Ahaia, (2) BET Solutions, Athens, Attiki, (3) Technological Educational Institute of Athens, Egaleo, Attiki, (4) University of Texas HSC SA, San Antonio, TX,


SU-F-T-50 (Sunday, July 31, 2016) 3:00 PM - 6:00 PM Room: Exhibit Hall

Pediatric tumors are generally treated with multi-modal procedures.Brachytherapy can be used with pediatric tumors, especially given that in this patient population low toxicity on normal tissues is critical as is the suppression of the probability for late malignancies.Our goal is to validate the GATE toolkit on realistic brachytherapy applications, and evaluate brachytherapy plans on pediatrics for accurate dosimetry on sensitive and critical organs of interest.

The GATE Monte Carlo (MC) toolkit was used.Two High Dose Rate (HDR) 192Ir brachytherapy sources were simulated (Nucletron mHDR-v1 and Varian VS2000), and fully validated using the AAPM and ESTRO protocols.A realistic brachytherapy plan was also simulated using the XCAT anthropomorphic computational model.The simulated data were compared to the clinical dose points. Finally, a 14 years old girl with vaginal rhabdomyosarcoma was modelled based on clinical procedures for the calculation of the absorbed dose per organ.

The MC simulations resulted in accurate dosimetry in terms of dose rate constant (Λ), radial dose gL(r) and anisotropy function F(r,θ) for both sources.The simulations were executed using ~1010 number of primaries resulting in statistical uncertainties lower than 2%.The differences between the theoretical values and the simulated ones ranged from 0.01% up to 3.3%, with the largest discrepancy (6%) being observed in the dose rate constant calculation.The simulated DVH using an adult female XCAT model was also compared to a clinical one resulting in differences smaller than 5%. Finally, a realistic pediatric brachytherapy simulation was performed to evaluate the absorbed dose per organ and to calculate DVH with respect to heterogeneities of the human anatomy.

GATE is a reliable tool for brachytherapy simulations both for source modeling and for dosimetry in anthropomorphic voxelized models. Our project aims to evaluate a variety of pediatric brachytherapy schemes using a population of pediatric phantoms for several pathological cases.

Funding Support, Disclosures, and Conflict of Interest: This study is part of a project that has received funding from the European Union Horizon2020 research and innovation programme under the MarieSklodowska-Curiegrantagreement No691203.Theresultspublishedinthis study reflect only the authors view and the ResearchExecutiveAgency(REA) and the EuropeanCommission is not responsible for any use that may be madeof the information it contains.

Contact Email: